- Home
- NWFL vs ACIU Comparison
NWFL vs ACIU Comparison
Compare NWFL & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWFL
- ACIU
- Stock Information
- Founded
- NWFL 1870
- ACIU 2003
- Country
- NWFL United States
- ACIU Switzerland
- Employees
- NWFL N/A
- ACIU N/A
- Industry
- NWFL Major Banks
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- NWFL Finance
- ACIU Health Care
- Exchange
- NWFL Nasdaq
- ACIU Nasdaq
- Market Cap
- NWFL 208.5M
- ACIU 168.7M
- IPO Year
- NWFL 1998
- ACIU 2016
- Fundamental
- Price
- NWFL $25.40
- ACIU $1.88
- Analyst Decision
- NWFL Buy
- ACIU Strong Buy
- Analyst Count
- NWFL 3
- ACIU 1
- Target Price
- NWFL $28.17
- ACIU $12.00
- AVG Volume (30 Days)
- NWFL 13.0K
- ACIU 116.1K
- Earning Date
- NWFL 07-25-2025
- ACIU 08-05-2025
- Dividend Yield
- NWFL 4.88%
- ACIU N/A
- EPS Growth
- NWFL N/A
- ACIU N/A
- EPS
- NWFL 0.14
- ACIU N/A
- Revenue
- NWFL $50,378,000.00
- ACIU $32,014,254.00
- Revenue This Year
- NWFL $79.38
- ACIU N/A
- Revenue Next Year
- NWFL $7.19
- ACIU $533.21
- P/E Ratio
- NWFL $180.40
- ACIU N/A
- Revenue Growth
- NWFL N/A
- ACIU 91.20
- 52 Week Low
- NWFL $21.25
- ACIU $1.43
- 52 Week High
- NWFL $34.50
- ACIU $4.41
- Technical
- Relative Strength Index (RSI)
- NWFL 47.84
- ACIU 51.75
- Support Level
- NWFL $24.80
- ACIU $1.83
- Resistance Level
- NWFL $27.06
- ACIU $2.10
- Average True Range (ATR)
- NWFL 0.66
- ACIU 0.15
- MACD
- NWFL -0.12
- ACIU -0.00
- Stochastic Oscillator
- NWFL 26.55
- ACIU 44.44
About NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.